Modified fixed flat wire bifurcated catheter and its application in lower extremity interventions

Information

  • Patent Grant
  • 11877940
  • Patent Number
    11,877,940
  • Date Filed
    Thursday, November 5, 2020
    4 years ago
  • Date Issued
    Tuesday, January 23, 2024
    9 months ago
Abstract
A bifurcated catheter and methods of use are disclosed herein. The bifurcated catheter can include a fixed flat wire that is configurable as a stabilization wire. The bifurcated catheter can be configured to improve the initial access and directability by application of a pull force to the stabilization wire, in addition to a push force from the proximal end of the bifurcated catheter. The stabilization wire is anchored once the bifurcated catheter is positioned. The anchored, bifurcated catheter provides stability and pushability to assist the procedural catheter in traversing the tortuous peripheral vasculature.
Description
TECHNICAL FIELD

The present disclosure relates to improved methods and apparatuses for traversing a tortuous vasculature. Specifically, the present disclosure relates to providing support to procedural catheters during lower extremity intervention procedures to traverse the procedural site through the tortuous access vessels.


BACKGROUND

Technology associated with interventional procedures is ever developing, particularly in the areas of stenting and balloon angioplasty of Interventional procedures are typically challenging, as accessing various regions of the artery can be dependent on the anatomical disposition of the access location. Specifically, accessing regions of a tortuous peripheral arteries and performing interventional procedures in a hostile anatomy can be very difficult. Furthermore, the subsequent removal of blockages and placement of a stent delivery system into aorto femoral arteries becomes more difficult, or in some instances impossible. The interventional procedure may also be difficult for the popliteal and tibial arteries. The stenting procedure is meant to re-establish a more normalized blood flow through these tortuous arteries by opening up regions constricted by plaque or embolic deposits, which inhibit blood flow.


Although the stent delivery systems are designed to accommodate very acute bends, they are reliant upon guide catheters, guide wires and/or embolic protection devices during deployment. When long delivery systems in tortuous arteries the pushability of catheters and guide wires become critical. As a result, the rigid or stiff catheters and guide wires are needed to manipulate the tortuous entry. With these type of rigid devices, injuries to the tortuous arteries and access vessels often occur during the insertion, manipulation and stabilization of the stent delivery mechanism. Injuries to the tortuous arteries and access vessels often occur during removal of the guide wires, secondary equipment and wires as well. Specifically, the injuries can be caused by puncturing or cutting into the arterial walls resulting in dissections and trauma to the vessels involved. These traumas can be dangerous to the patient as they can ultimately affect blood flow by leakage at the dissections. In some instances, the traumas can create accumulation of thrombus, which is an organization of white blood cells. Dissections and the accumulation of thrombus can require additional procedures to repair and heal the damaged artery walls.


In view of the foregoing, there exists a need to provide a simplified procedure that reduces the injuries caused to the arterial walls during lower extremity interventions. Furthermore, there exists a need to for a usable sheath and catheter stabilization system than enable the use of softer catheters and less stiff guide wires for the treatment of lower extremities.





BRIEF DESCRIPTION OF THE DRAWINGS

In order to describe the manner in which the above-recited disclosure and its advantages and features can be obtained, a more particular description of the principles described above will be rendered by reference to specific examples illustrated in the appended drawings. These drawings depict only example aspects of the disclosure, and are therefore not to be considered as limiting of its scope. These principles are described and explained with additional specificity and detail through the use of the following drawings.



FIG. 1 illustrates tortuous arteries of the lower extremities, in accordance with an embodiment of the disclosure.



FIG. 2 illustrates a tortuous anatomical pathway from the percutaneous access within the common femoral artery to a potential procedure location on the ipsilateral side, in accordance with an embodiment of the disclosure.



FIG. 3 illustrates a fixed flat-wire bifurcated catheter, in accordance with an embodiment of the disclosure.



FIG. 4 illustrates the fixed flat-wire catheter in the commission of an interventional process, in accordance with one embodiment of the disclosure.



FIG. 5 illustrates a process for introducing a snare catheter and extending a snare wire to an aortic bifurcation, in accordance with an embodiment of the disclosure.



FIG. 6 illustrates a process for inserting a fixed stabilization wire into a main sheath and capturing a stabilization wire extension, in accordance with an embodiment of the disclosure.



FIG. 7 illustrates a process for advancing the bifurcated catheter into the ipsilateral iliac artery, in accordance with one embodiment of the disclosure.



FIG. 8 illustrates a process for advancing the bifurcated catheter into the ipsilateral femoral artery with the stabilization wire externalized and anchored, in accordance with one embodiment of the disclosure.



FIG. 9 illustrates a process for providing stability, tension and pushability of the bifurcated catheter, in accordance with an embodiment of the disclosure.





DETAILED DESCRIPTION OF ILLUSTRATED EMBODIMENTS

The present invention is described with reference to the attached figures, where like reference numerals are used throughout the figures to designate similar or equivalent elements. The figures are not drawn to scale, and they are provided merely to illustrate the instant invention. Several aspects of the invention are described below with reference to example applications for illustration. It should be understood that numerous specific details, relationships, and methods are set forth to provide a full understanding of the invention. One having ordinary skill in the relevant art, however, will readily recognize that the invention can be practiced without one or more of the specific details, or with other methods. In other instances, well-known structures or operations are not shown in detail to avoid obscuring the invention. The present invention is not limited by the illustrated ordering of acts or events, as some acts may occur in different orders and/or concurrently with other acts or events. Furthermore, not all illustrated acts or events are required to implement a methodology in accordance with the present disclosure.


The present disclosure provides a system and method for providing access to tortuous arteries to perform lower extremity interventions. The present disclosure is directed towards employing a flat fixed wire bifurcated catheter. The flat fixed wire bifurcated catheter includes a flat wire fixed along the length of the bifurcated catheter from its proximal end to the bifurcation. The flat wire can emerge from a side hole at the bifurcation end of the bifurcated catheter to extend for an additional length beyond the bifurcation. The distal end of the bifurcated catheter can be configured to have a dual lumen (e.g., a large procedural lumen and a small stabilization lumen) from which the flat wire emerges. Alternatively, the distal end of the bifurcated catheter can be configured to have a procedural lumen and a side hole for the stabilization wire.


A small sheath can be provided to enable percutaneous access for the distal end of the support wire. A push and pull force can be applied to the bifurcated catheter to enable the bifurcated catheter to traverse the tortuous vessels to the site of the bifemoral bypass location. This process allows the bifurcated catheter to be positioned in either the common femoral artery or the proximal superficial femoral artery. Furthermore, the stabilization wire can be locked at the accesses to apply tension and stabilization to the procedural lumen.


It should be understood by one of ordinary skill in the art, that the disclosed apparatus can be implemented in any type of lower extremity peripheral arterial intervention. In addition, the disclosed apparatus can be implemented within the internal iliac artery vascular distribution (e.g., uterine artery embolization, prostate artery embolization, proximal internal iliac artery embolization prior to endovascular common iliac artery aneurysm repair, etc.). The disclosed system and method can reduce injury to the vessels within the arteries, reduce trauma caused during the intervention procedure, and improve the procedural success rate. The disclosed system and method can also improve navigation speed through difficult anatomy and enhance stability.



FIG. 1 illustrates an exemplary tortuous vessel artery 100, in accordance with an embodiment of the disclosure. The tortuous vessel artery 100 can include an abdominal aortic bifurcation with tortuous branch arteries. The tortuous branch arteries can include a right renal artery 101b and a left renal artery 101a extending from an abdominal aorta 102. The abdominal aorta 102 can be parted at an aortic bifurcation 115, and connected to arteries of the lower limbs. The arteries of the lower limbs can include a right common iliac 103 and a left common iliac 104. The left common iliac 104 can be split into a left external iliac 106 and a left internal iliac 112a. The left external iliac 106 can be connected to a left common femoral 108, and further split into a left deep femoral 113a, and a left superficial femoral 110. The


The right common iliac 103 can be split into a right external iliac 105 and a right internal iliac 112b. The right external iliac 105 can be connected to a right common femoral 107, which splits into a right deep femoral 113b and a right superficial femoral 109. FIG. 1 illustrates the tortuous nature of the peripheral arteries.


When performing interventions within the tortuous vessel artery 100, it is common to encounter difficulties associated with pushability and torque. As the catheters and wires are guided over a highly angulated aortic bifurcation 115 or through the extremely tortuous common iliac arteries 103 and 104, it can be extremely difficult to apply torque. Furthermore, these arteries can contain calcific plaques or other obstructions which can add anatomic and technical challenges with traversing the tortuous vessel artery 100.



FIG. 2 illustrates a tortuous anatomical pathway 200 from the percutaneous access within the common femoral artery to a potential procedure location on the ipsilateral side, in accordance with an embodiment of the disclosure. In some embodiments, interventional devices such as wires and catheters are pushed from the contralateral access at point ‘X’ to the treatment site ‘Y’. The devices would need to travel through the general pathways 1 through 9. Due to the multi directional twists and turns along the pathways 1 through 9, the devices can suffer from a significant loss of performance such as torque and pushability. While FIG. 2 illustrates the tortuous anatomical pathway 200 in a two-dimensional format, the tortuosity of the anatomical pathway 200 is often significantly more severe, as illustrated in FIG. 1.



FIG. 3 illustrates a bifurcated catheter 300, in accordance with an embodiment of the disclosure. The bifurcated catheter 300 can include a bifurcated sheath 301 and a fixed flat-wire 302. The fixed flat wire 302 can be integrated within the bifurcated catheter 300. This is discussed in greater detail below.


The bifurcated catheter can have a proximal end (not shown) and a distal end. The distal end can include a side hole 305 for a stabilization wire. The fixed flat wire 302 can be extended from the proximal end (not shown) of the bifurcated catheter 300 to the side hole 305. The bifurcated catheter 300 can also include a bifurcated sheath 301 that spans almost the entire length of the bifurcated catheter 300. In some embodiments, the bifurcation sheath 301 is approximately 2 centimeters from the distal end of the bifurcated catheter 300. For example, in some embodiments the bifurcated catheter 300 can include a radio opaque band 304 at its distal end that limits the length of the bifurcated sheath 301.


The radio opaque band 304 can be implemented to track the distal end of the bifurcated catheter 300 as it is advanced through the arteries of FIG. 1. The bifurcated catheter 300 can also have a procedural lumen 303. In some embodiments, the procedural lumen 303 can extend from its proximal end to its distal end. The bifurcated catheter 300 can also have a stabilization wire 306. The stabilization wire 306 can be configured to protrude from the bifurcated catheter 300 at the side hole 305. In some embodiments, the stabilization wire 306 can extend up to 10 cm beyond the end of the bifurcated catheter 300.


Furthermore, the stabilization wire 306 can be a flat wire or a round wire. For example, the stabilization wire 306 can be made up of a solid or hollow member with a cross-section that is round, flat, rectangular, or a combination thereof. The stabilization wire 306 can be fabricated using commonly known materials in the art including, for example, stainless steel, nickel titanium, composites, metal reinforced polymer, polymer, a combination thereof, or the like.



FIGS. 4 to 8 illustrate an exemplary process for lower extremity intervention implementing the bifurcated catheter 300 of FIG. 3. The lower extremity intervention can include, for example, an Aorto Bifemoral Bypass or a tortuous aortoiliac artery treatment. Furthermore, FIGS. 4 to 8 illustrate the process of providing end-to-end stability to any additional procedural catheter and instruments introduced through the procedural lumen 303 of the bifurcated catheter 300.



FIG. 4 illustrates a diagram 400 where a percutaneous contralateral femoral access 402 is introduced into the right common femoral artery 107. The percutaneous contralateral femoral access 402 can be implemented to introduce a main access sheath 401 into the right common femoral artery 107. The main access sheath 401 can be configured as a 7 Fr. vascular sheath. The main access sheath 401 can be advanced through the right external 105 and right common iliac 103 to the aortic bifurcation 115. The main access sheath 401 can be tracked using the radio opaque band 304 as the main access sheath 401 is advanced to the aortic bifurcation 115. FIG. 4 also illustrates the introduction of a percutaneous ipsilateral femoral access 404 into the left common femoral artery 108. The percutaneous ipsilateral femoral access 404 can be introduced for a snare access sheath 403 of a 4 Fr. internal lumen.



FIG. 5 illustrates a process for introducing a snare catheter and extending a snare wire to an aortic bifurcation, in accordance with an embodiment of the disclosure. Once the access sheaths 401 and 403 are in place, a 4 Fr snare sheath 504 and snare wire 506 can be introduced through the retrograde snare access sheath 403. In some embodiments, the snare wire 506 can include a snare 505 at its distal end extending to the aortic bifurcation 115. The snare 505 can be 20 to 30 mm (or smaller) in length. In some embodiments, the fixed flat wire bifurcated catheter 300 can include a dialator 503 in the main sheath. The fixed flat wire bifurcated catheter 300 and the stabilization wire 306 can be introduced through the main access sheath 401. The main access sheath 401 can include a distal end, labeled as the tip of the sheath aligned to the aortic bifurcation. FIG. 5 further illustrates the fixed flat wire bifurcated catheter 300 and the stabilization wire 306 being pushed through the distal end of the main sheath 401. The stabilization wire 306 can be extended out of the distal end of the main sheath 401 to be captured at the distal end of the snare 505.



FIG. 6 illustrates a process for inserting a fixed stabilization wire into a main sheath and capturing a stabilization wire extension, in accordance with an embodiment of the disclosure. The stabilization wire 306 can be tightened to a snare knot 601. A pull force 703 can be applied to the distal end of the bifurcated catheter 300. The pull force 703 can be derived from the snare catheter 504 and the snare wire 506, which has snared the stabilization wire 306. A push force 701 can be applied on the proximal end of the bifurcated catheter 300. The push force 701 and the pull force 703 can be applied simultaneously. The push force 701 and the pull force 703 guides the distal end of the bifurcated catheter 300 with the dilator tip 503 over the aortic bifurcation and down the ipsilateral left iliac arteries 104 and 105.



FIG. 7 illustrates a process for advancing the bifurcated catheter into the ipsilateral iliac artery, in accordance with one embodiment of the disclosure. Once guided over the aortic bifurcation and down the ipsilateral left iliac arteries 104 and 105, the bifurcated catheter 300 can be guided to the left common femoral artery 108. The snare wire 506, encompassing the snared stabilization wire 306, can be pulled out of the ipsilateral snare access sheath 403 and anchored.



FIG. 8 illustrates a process for advancing the bifurcated catheter into the ipsilateral femoral artery with the stabilization wire externalized and anchored, in accordance with one embodiment of the disclosure. The snare wire 506 can be anchored with the snared stabilization wire 306 locking the snare wire external to the snare access sheath. The snare wire can be locked to the snare access sheath using a wire lock 801. By locking the stabilization wire 306 outside the snare access 403 and providing a pull force on the distal end of the bifurcated catheter, a tension can be applied to the main procedural lumen 303. This tension can provide stabilization to the main procedural lumen 303. Any procedural catheters and instruments within the main procedural lumen 303 can also be stabilized. Anchoring and locking the stabilization wire can cause bifurcation of the bifurcated catheter at the snare access sheath. This bifurcation can provide an anchor point for improved pushability to the procedural catheters.



FIG. 9 illustrates a process 900 for providing stability, tension and pushability of the bifurcated catheter of FIG. 3, in accordance with an embodiment of the disclosure.


At step 901, a small 4 Fr lumen snare access sheath is inserted into the left common femoral artery to provide an ipsilateral retrograde access. A snare catheter is inserted through the snare access sheath with a snare wire. The snare catheter can be 4 Fr or smaller. The snare wire can have a 20-30 mm snare at its distal end. In some embodiments, the snare wire can have a snare less than 20 mm at its distal end. The snare wire can be guided to the aortic bifurcation.


At step 902, a main access sheath can be used to establish a contralateral retrograde access at the right common femoral artery location. The main access sheath can be a 7 Fr. Lumen. A large sheath catheter can be advanced up the right femoral artery and the iliac arteries towards the aortic bifurcation. The large sheath catheter can be guided using radiographic imaging. The large sheath catheter can be Fr.7.


At step 903, a modified bifurcated catheter can be inserted into the main sheath and guided to the aortic bifurcation. The modified bifurcated catheter can have a fixed flat wire secured to the bifurcated catheter, from its proximal end to the bifurcation. An extension of the flat wire can emerge through a side exit hole at the bifurcation. The extension can be the stabilization wire. The side exit hole at the bifurcation can be between 2-4 cm prior to the distal end of the bifurcated catheter. In some embodiments, the stabilization wire can have a length of 6 to 13 cm beyond the side exit hole. In alternative embodiments, the stabilization wire can be extended beyond 13 cm from the side exit hole.


At step 904 the stabilization wire, extending from the side exit hole, can be captured by the snare of the snare wire. The snare wire can capture the stabilization wire at the aortic bifurcation. The snare can be tightened to secure the stabilization wire and apply a pull pressure on it.


At step 905 a reverse curve catheter can be inserted through the main lumen of the bifurcated catheter to access the left common iliac artery. The reverse curve catheter can assist in transitioning the bifurcated catheter from the contralateral right common iliac artery to the ipsilateral left common iliac artery over the aortic bifurcation.


At step 906, an external pull force can be applied on the snare wire with the stabilization wire snared. The pull force can be accomplished by implementing a small stabilization sheath. By pulling the small stabilization sheet, the attached fixed flat wire and the main lumen are also pulled over the reverse curve catheter into the contralateral common left iliac artery.


At step 907 a push force is applied on the bifurcated catheter at its proximal end to assist advance the bifurcated catheter past sharp corners and reduce tension on the catheter as it is pulled by the stabilization wire. The combination of the push and pull force enable the bifurcated catheter to easily overcome obstructions as it traverses tortuous curves of the vessels. The combination of push and pull forces also help to reduce the tension on the bifurcated catheter and increase access while reducing the trauma to the vessels.


At step 908 the bifurcated sheath is simultaneously pulled and pushed down the ipsilateral left side vasculature, until the side exit hole of the stabilization wire is at the ipsilateral snare access sheath location. The stabilization wire is externalized by pulling the snare wire out of the access sheath through the ipsilateral access.


At step 909 the externalized stabilization wire is anchored by locking it in place at the ipsilateral access by a wire lock. The modified bifurcated catheter is anchored at the distal end of the bifurcation.


At step 910, a tension is applied to the fixed Flat wire at the proximal end of the bifurcated catheter. The tension is applied at the contralateral access with the stabilization wire. The stabilization wire can be locked in place at the distal end. An end-to-end application of tension can be applied to provide stability to the bifurcated catheter. This stability increases pushability of any procedural catheters within its main procedural lumen.


At step 911 any optional reverse curve catheter can be used. Furthermore, any dialator used to reduce trauma to vessels can be removed from the bifurcated catheter.


At step 912 the bifurcated catheter is configured to accept the procedural catheters and instruments for procedure, through its main lumen. Stabilization and tension can be provided by the locked stabilization wire at the distal end of the bifurcation and the fixed flat wire. The bifurcated catheter is configured for interventional procedures (stents, atherectomy, etc.) within the left peripheral vasculature. The process 900 is terminated after step 912.


The examples provided herein are directed towards specific examples. One of ordinary skill in the art would understand the provided examples are not intended to be exhaustive. There exists other exemplary access and stabilization of a procedural catheter or sheath. As is well understood, the preferred method will vary based on the location of the procedure and the physical condition of the patient.


As is well understood by those familiar with the art, the invention may be embodied in other specific forms without departing from the spirit or essential characteristics thereof. Likewise, the naming and division of the members, features, attributes, and other aspects are not mandatory or significant, and the mechanisms that implement the invention or its features may have different structural construct, names, and divisions. Accordingly, the disclosure of the invention is intended to be illustrative, but not limiting, of the scope of the invention.


The embodiments disclosed herein can be implemented as hardware, firmware, software, or any combination thereof. Moreover, the software is preferably implemented as an application program tangibly embodied on a program storage unit or computer readable medium. The application program may be uploaded to, and executed by, a machine comprising any suitable architecture.

Claims
  • 1. A system comprising: a bifurcated catheter comprising a proximal end, a distal end and a bifurcation between the proximal end and the distal end, the bifurcated catheter further comprising a side hole near the distal end of the bifurcated catheter;a stabilization wire attached to a wall of the bifurcated catheter,a snare access sheath; anda snare catheter configured to be inserted through the snare access sheath, the snare catheter comprising a snare wire,wherein the snare wire is configured to snare a distal end of the stabilization wire,wherein the stabilization wire is configured to emerge and extend from the side hole and wherein the stabilization wire is configured to be pulled to guide and stabilize the bifurcated catheter, andwherein the snare wire is configured to be externalized to lock the distal end of the stabilization wire at a first location and wherein the bifurcated catheter is configured to be locked at a second location to apply tension to the bifurcated catheter.
  • 2. The system of claim 1, wherein the bifurcation is 2 cm from the distal end of the bifurcated catheter.
  • 3. The system of claim 1, wherein the stabilization wire is configured to extend at least 10 cm beyond the bifurcation.
  • 4. The system of claim 1, wherein the bifurcated catheter further comprises a procedural lumen and a stabilization lumen.
  • 5. The system of claim 4, wherein the stabilization wire is configured to emerge from the stabilization lumen at the side hole.
  • 6. The system of claim 4, wherein the procedural lumen is larger than the stabilization lumen.
  • 7. The system of claim 1, wherein the bifurcated catheter is configured for arterial access via a percutaneous contralateral arterial access.
  • 8. The system of claim 1, wherein the bifurcated catheter comprises a procedural lumen, and wherein the stabilization wire is configured to emerge from the procedural lumen at the side hole.
  • 9. The system of claim 1, further comprising a sheath configured to provide percutaneous ipsilateral access for a distal end of the stabilization wire.
  • 10. The system of claim 1, wherein the bifurcated catheter is configured to receive a pull force and a push force to advance the bifurcated catheter through tortuous vessels to a site of a lower extremity intervention procedure.
  • 11. The system of claim 1, wherein the stabilization wire is configured to apply tension and stabilization to the procedural lumen for access to a procedural location.
  • 12. The system of claim 1, wherein the stabilization wire comprises a fixed wire portion attached to the bifurcated catheter and wherein the portion of the stabilization wire that emerges from the side hole comprises a stabilization wire extension.
  • 13. The system of claim 1, wherein the bifurcated catheter comprises a radio opaque band.
  • 14. The system of claim 1, wherein the proximal end of the stabilization wire is affixed to the bifurcated catheter at the second location and wherein the distal end of the stabilization wire extends from the side hole beyond the distal end of the bifurcated catheter.
  • 15. The system of claim 14, wherein a combination of push and pull forces are configured to be applied to the bifurcated catheter by the stabilization wire.
  • 16. The system of claim 1, wherein the snare wire is configured to snares the distal end of the stabilization wire using a snare knot.
  • 17. A system comprising: a bifurcated catheter comprising a proximal end, a distal end and a bifurcation between the proximal end and the distal end, the bifurcated catheter further comprising a procedural lumen; anda stabilization wire attached to a wall of the procedural lumen,a snare access sheath; anda snare catheter configured to be inserted through the snare access sheath, the snare catheter comprising a snare wire,wherein the snare wire is configured to snare a distal end of the stabilization wire,wherein the stabilization wire extends within the procedural lumen from the proximal end to the distal end of the bifurcated catheter and further extends beyond the distal end of the bifurcated catheter, andwherein the snare wire is configured to be externalized to lock the distal end of the stabilization wire at a first location and wherein the bifurcated catheter is configured to be locked at a second location to apply tension to the bifurcated catheter.
  • 18. The system of claim 17, wherein a proximal end of the stabilization wire is affixed to the bifurcated catheter at the second location and wherein the distal end of the stabilization wire extends from a side hole beyond the distal end of the bifurcated catheter.
  • 19. The system of claim 18, wherein a combination of push and pull forces are configured to be applied to the bifurcated catheter by the stabilization wire.
  • 20. The system of claim 17, wherein the snare wire is configured to snare the distal end of the stabilization wire using a snare knot.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 16/183,066, entitled “A MODIFIED FIXED FLAT WIRE BIFURCATED CATHETER AND ITS APPLICATION IN LOWER EXTREMITY INTERVENTIONS,” and filed on Nov. 7, 2018, which claims priority under 35 U.S.C. § 119 to U.S. Provisional Application No. 62/631,904, entitled “MODIFIED FIXED FLAT WIRE BIFURCATED CATHETER AND ITS APPLICATION IN AORTO BIFEMORAL BYPASS,” and filed on Feb. 18, 2018, the contents of each of which are hereby incorporated by reference in their entirety.

US Referenced Citations (221)
Number Name Date Kind
3896815 Fettel Jul 1975 A
4243040 Beecher Jan 1981 A
4790331 Okada et al. Dec 1988 A
5098707 Baldwin et al. Mar 1992 A
5293772 Carr, Jr. Mar 1994 A
5344426 Lau et al. Sep 1994 A
5419777 Hofling May 1995 A
5433705 Giebel et al. Jul 1995 A
5571135 Fraser et al. Nov 1996 A
5651366 Liang et al. Jul 1997 A
5653743 Martin Aug 1997 A
5662703 Yurek et al. Sep 1997 A
5669924 Shaknovich Sep 1997 A
5690644 Yurek et al. Nov 1997 A
5718702 Edwards Feb 1998 A
5720735 Dorros Feb 1998 A
5766192 Zacca Jun 1998 A
5807330 Teitelbaum Sep 1998 A
5813976 Filipi et al. Sep 1998 A
5824055 Spiridigliozzi Oct 1998 A
5957901 Mottola et al. Sep 1999 A
5997563 Kretzers Dec 1999 A
6027462 Greene et al. Feb 2000 A
6059813 Vrba et al. May 2000 A
6070589 Keith et al. Jun 2000 A
6152141 Stevens et al. Nov 2000 A
6224587 Gibson May 2001 B1
6238410 Vrba et al. May 2001 B1
6245017 Hashimoto Jun 2001 B1
6245573 Spillert Jun 2001 B1
6428567 Wilson et al. Aug 2002 B2
6450964 Webler Sep 2002 B1
6464665 Heuser Oct 2002 B1
6494875 Mauch Dec 2002 B1
6544278 Vrba et al. Apr 2003 B1
6652556 Vantassel Nov 2003 B1
6663613 Lewis et al. Dec 2003 B1
6764505 Hossainy et al. Jul 2004 B1
6780174 Mauch Aug 2004 B2
6808520 Fouirkas et al. Oct 2004 B1
6837881 Barbut Jan 2005 B1
6929633 Evans et al. Aug 2005 B2
6932829 Majercak Aug 2005 B2
6942682 Vrba et al. Sep 2005 B2
7235083 Perez Jun 2007 B1
7393358 Malewicz Jul 2008 B2
7651520 Fischell et al. Jan 2010 B2
7674493 Hossainy et al. Mar 2010 B2
7740791 Kleine et al. Jun 2010 B2
7758624 Dorn et al. Jul 2010 B2
7763010 Evans et al. Jul 2010 B2
7766961 Patel et al. Aug 2010 B2
7828832 Belluche et al. Nov 2010 B2
7842026 Cahill et al. Nov 2010 B2
7955370 Gunderson Jun 2011 B2
8092509 Dorn et al. Jan 2012 B2
8119184 Hossainy et al. Feb 2012 B2
8202309 Styrc Jun 2012 B2
8241241 Evans et al. Aug 2012 B2
8343181 Duffy et al. Jan 2013 B2
8419767 Al-Qbandi et al. Apr 2013 B2
8535290 Evans et al. Sep 2013 B2
8721714 Kelley May 2014 B2
8727988 Flaherty et al. May 2014 B2
8728144 Fearnot May 2014 B2
8740971 Iannelli Jun 2014 B2
8986241 Evans et al. Mar 2015 B2
8998894 Mauch et al. Apr 2015 B2
9301830 Heuser et al. Apr 2016 B2
9314499 Wang et al. Apr 2016 B2
9414824 Fortson Aug 2016 B2
9636244 Syed May 2017 B2
9855705 Wang et al. Jan 2018 B2
9980838 Syed May 2018 B2
10492936 Syed Dec 2019 B2
10779976 Syed Sep 2020 B2
10857014 Syed Dec 2020 B2
10888445 Syed Jan 2021 B2
11007075 Bagoaisan May 2021 B2
11020256 Syed Jun 2021 B2
20010003985 Lafontaine et al. Jun 2001 A1
20010049534 Lachat Dec 2001 A1
20020077691 Nachtigall Jun 2002 A1
20020123698 Garibotto et al. Sep 2002 A1
20020156518 Tehrani Oct 2002 A1
20020165535 Lesh Nov 2002 A1
20030088187 Saadat et al. May 2003 A1
20030204171 Kucharczyk Oct 2003 A1
20030216721 Diederich Nov 2003 A1
20030229282 Burdette Dec 2003 A1
20040002714 Weiss Jan 2004 A1
20040073190 Deem et al. Apr 2004 A1
20040127975 Levine Jul 2004 A1
20040138734 Chobotov et al. Jul 2004 A1
20040147837 Macaulay et al. Jul 2004 A1
20040167463 Zawacki Aug 2004 A1
20050043779 Wilson Feb 2005 A1
20050101968 Dadourian May 2005 A1
20050113798 Slater May 2005 A1
20050113862 Besselink May 2005 A1
20050222488 Chang et al. Oct 2005 A1
20050234499 Olson et al. Oct 2005 A1
20050251160 Saadat et al. Nov 2005 A1
20050267010 Goodson et al. Dec 2005 A1
20060025752 Broaddus et al. Feb 2006 A1
20060025844 Majercak et al. Feb 2006 A1
20060030923 Gunderson Feb 2006 A1
20060036218 Goodson Feb 2006 A1
20060074484 Huber Apr 2006 A1
20060155363 Laduca et al. Jul 2006 A1
20060200221 Malewicz Sep 2006 A1
20060257389 Binford Nov 2006 A1
20060259063 Bates et al. Nov 2006 A1
20060270900 Chin et al. Nov 2006 A1
20070016019 Salgo Jan 2007 A1
20070016062 Park Jan 2007 A1
20070038061 Huennekens et al. Feb 2007 A1
20070038293 St. Goar et al. Feb 2007 A1
20070049867 Shindelman Mar 2007 A1
20070083215 Hamer et al. Apr 2007 A1
20070118151 Davidson et al. May 2007 A1
20070129719 Kendale et al. Jun 2007 A1
20070219614 Hartley et al. Sep 2007 A1
20070288082 Williams Dec 2007 A1
20080009829 Ta Jan 2008 A1
20080039746 Hissong et al. Feb 2008 A1
20080114239 Randall et al. May 2008 A1
20080172122 Mayberry Jul 2008 A1
20080194993 Mclaren et al. Aug 2008 A1
20080208309 Saeed Aug 2008 A1
20080281398 Koss Nov 2008 A1
20080306467 Reydel Dec 2008 A1
20090005679 Dala-Krishna Jan 2009 A1
20090018526 Power et al. Jan 2009 A1
20090036780 Abraham Feb 2009 A1
20090132019 Duffy et al. May 2009 A1
20090171293 Yang et al. Jul 2009 A1
20090177035 Chin Jul 2009 A1
20090240253 Murray Sep 2009 A1
20090254116 Rosenschein et al. Oct 2009 A1
20090270975 Giofford, III et al. Oct 2009 A1
20090319017 Berez et al. Dec 2009 A1
20100016943 Chobotov Jan 2010 A1
20100024818 Stenzler et al. Feb 2010 A1
20100030165 Takagi et al. Feb 2010 A1
20100030256 Dubrul et al. Feb 2010 A1
20100069852 Kelley Mar 2010 A1
20100168583 Dausch et al. Jul 2010 A1
20100185161 Pellegrino et al. Jul 2010 A1
20100185231 Lashinski Jul 2010 A1
20100204708 Sharma Aug 2010 A1
20100211095 Carpenter Aug 2010 A1
20100268067 Razzaque et al. Oct 2010 A1
20100272740 Vertegel et al. Oct 2010 A1
20100298922 Thornton et al. Nov 2010 A1
20110009943 Paul et al. Jan 2011 A1
20110034804 Hubregtse Feb 2011 A1
20110034987 Kennedy Feb 2011 A1
20110071394 Fedinec Mar 2011 A1
20110082533 Vardi et al. Apr 2011 A1
20110098681 Djurivic Apr 2011 A1
20110196420 Ebner Aug 2011 A1
20110224773 Gifford et al. Sep 2011 A1
20110230830 Gifford, III et al. Sep 2011 A1
20110270375 Hartley et al. Nov 2011 A1
20120016343 Gill Jan 2012 A1
20120016454 Jantzen Jan 2012 A1
20120020942 Hall et al. Jan 2012 A1
20120022636 Chobotov Jan 2012 A1
20120029478 Kurosawa Feb 2012 A1
20120034205 Alkon Feb 2012 A1
20120035590 Whiting et al. Feb 2012 A1
20120046690 Blom Feb 2012 A1
20120169712 Hill et al. Jul 2012 A1
20120209375 Madrid et al. Aug 2012 A1
20120221094 Cunningham Aug 2012 A1
20120289945 Segermark Nov 2012 A1
20130053792 Fischell et al. Feb 2013 A1
20130131777 Hartley et al. May 2013 A1
20130218201 Obermiller Aug 2013 A1
20130296773 Feng et al. Nov 2013 A1
20130310823 Gelfand et al. Nov 2013 A1
20130331819 Rosenman et al. Dec 2013 A1
20130331921 Roubin Dec 2013 A1
20140031925 Garrison et al. Jan 2014 A1
20140114346 McCaffrey Apr 2014 A1
20140142427 Petroff May 2014 A1
20140214002 Lieber et al. Jul 2014 A1
20140214048 Gulcher Jul 2014 A1
20140228808 Webster et al. Aug 2014 A1
20140276602 Bonnette Sep 2014 A1
20140358123 Kaisha Dec 2014 A1
20150018942 Hung et al. Jan 2015 A1
20150174377 Syed Jun 2015 A1
20150190576 Lee et al. Jul 2015 A1
20150201900 Syed Jul 2015 A1
20150245933 Syed Sep 2015 A1
20150352331 Helm, Jr. Dec 2015 A1
20150366536 Courtney et al. Dec 2015 A1
20150374261 Grunwald Dec 2015 A1
20160008058 Hu et al. Jan 2016 A1
20160038724 Madsen et al. Feb 2016 A1
20160120509 Syed May 2016 A1
20160120673 Siegel et al. May 2016 A1
20160296355 Syed Oct 2016 A1
20160338835 Van Bladel et al. Nov 2016 A1
20170119562 Syed May 2017 A1
20170119563 Syed May 2017 A1
20170135833 Syed May 2017 A1
20170181876 Syed Jun 2017 A1
20170304095 Syed Oct 2017 A1
20170361062 Syed Dec 2017 A1
20180042743 Syed Feb 2018 A1
20180059124 Syed Mar 2018 A1
20180116780 Laine May 2018 A1
20180250147 Syed Sep 2018 A1
20190091441 Syed Mar 2019 A1
20190336114 Syed Nov 2019 A1
20200038210 Syed Feb 2020 A1
20210196492 Bagaoisan Jul 2021 A1
20220152347 Syed May 2022 A1
Foreign Referenced Citations (33)
Number Date Country
108472124 Aug 2018 CN
108472472 Aug 2018 CN
108882975 Nov 2018 CN
109475722 Mar 2019 CN
111629696 Sep 2020 CN
3280355 Feb 2018 EP
3367969 Sep 2018 EP
3368123 Sep 2018 EP
3399944 Nov 2018 EP
3405261 Nov 2018 EP
3471815 Apr 2019 EP
3752104 Dec 2020 EP
201827018555 Oct 2018 IN
201827018768 Oct 2018 IN
201827019509 Oct 2020 IN
WO 1996036269 Nov 1996 WO
199940849 Aug 1999 WO
WO 2004089249 Oct 2004 WO
WO 2010129193 Nov 2010 WO
WO 2011011539 Jan 2011 WO
WO 2011106502 Sep 2011 WO
WO 2011137336 Nov 2011 WO
WO 2012030101 Aug 2012 WO
WO 2014081947 May 2014 WO
WO 2014197839 Dec 2014 WO
WO 2016164215 Oct 2016 WO
WO 2017074492 May 2017 WO
WO 2017074536 May 2017 WO
WO 2017127127 Jul 2017 WO
WO 2017222571 Dec 2017 WO
WO 2017222612 Dec 2017 WO
WO 2018164766 Sep 2018 WO
WO 2019070349 Apr 2019 WO
Non-Patent Literature Citations (28)
Entry
International Search Report and Written Opinion for PCT/US2013/071271 dated Feb. 10, 2014, 7 pages.
International Search Report and Written Opinion for PCT/US2016/024794 dated Jul. 1, 2016, 10 pages.
International Search Report and Written Opinion for PCT/US2016/024795 dated Aug. 30, 2016, 14 pages.
International Search Report and Written Opinion for PCT/US2016/047163 dated Oct. 28, 2016, 9 pages.
International Search Report and Written Opinion for PCT/US2016/047165 dated Jan. 5, 2017, 13 pages.
International Search Report and Written Opinion for PCT/US2017/021188 dated May 10, 2017, 11 pages.
International Search Report and Written Opinion for PCT/US2018/012834 dated Mar. 15, 2018,13 pages.
International Search Report and Written Opinion for PCT/US2018/047372 dated Jan. 2, 2019, 8 pages.
International Search Report and Written Opinion for PCT/US2019/012727 dated Mar. 21, 2019, 12 pages.
International Search Report and Written Opinion for PCT/US2019/12745 dated Apr. 1, 2019, 10 pages.
International Preliminary Report on Patentability for PCT/US2013/071271 dated May 26, 2015, 6 pages.
International Preliminary Report on Patentability for PCT/US2016/024795 dated May 1, 2018, 10 pages.
International Preliminary Report on Patentability for PCT/US2016/047165 dated May 1, 2018, 5 pages.
International Preliminary Report on Patentability for PCT/US2017/021188 dated Dec. 25, 2018, 9 pages.
International Preliminary Report on Patentability for PCT/US2016/047163 dated Dec. 25, 2018, 7 pages.
EP 16777055.1 Extended Search Report dated Feb. 12, 2019, 7 pages.
EP 18725097.2 Extended Search Report dated Apr. 24, 2019, 9 pages.
EP 16860437.9 Extended Search Report dated May 17, 2019.
EP 16906475.5 Extended Search Report dated Jan. 24, 2020.
EP 17815838.2 Extended Search Report dated Jan. 20, 2020.
Beckman et al., Venous Thromboembolism: A Public Health Concern, Am J Prev Med., 2010, vol. 38(4), pp. S495-501.
Blaney et al., Alteplase for the Treatment of Central Venous Catheter Occlusion in Children: Results of a Prospective, Open-Label, Single-Arm Study (The Cathflo Activase Pediatric Study), J Vase Interv Radiol, 2006, vol. 17(11), pp. 1745-1751.
Godwin, J., The Circulatory and Respiratory Systems, Z0250 Lab III, 2002, retrieved from: https://projects.ncsu.edu/cals/course/zo250/lab-3.html.
Meunier et al., Individual Lytic Efficacy of Recombinant Tissue Plasminogen Activator in an in-vitro Human Clot Model: Rate of Nonresponse Acad Emerg Med., 2013, vol. 20(5), pp. 449-455.
Schwartz et al., Intracardiac Echocardiography in Humans using a Small-Sized (6F), Low Frequency (12.5 MHz) Ultrasound Catheter Methods, Imaging Planes and Clinical Experience, Journal of the American College of Cardiology, 1993, vol. 21(1), pp. 189-198.
Shah, T., Radiopaque Polymer Formulations for Medical Devices, MDDI Medical Diagnostic and Device Industry: Materials, 2001, retrieved from: https://www.mddionline.com/radiopaque-polymer-formulations-medical-devices.
Tripathi et al., Use of Tissue Plasminogen Activator for Rapoid Dissolution of Fibrin and Blood Clots in the Eye After Surgery for Claucomoa and Cataract in Humans, Drug Development Research, 1992, vol. 27(2), pp. 147-159.
Stroke Treatments, American Heart Association, Retrieved from: http://www.strokeassociation.org/STROKEORG/AboutStroke/Treatment/Stroke-Treatments_UCM_310892_Article.jsp#V9Hrg2WfV_1 on Sep. 8, 2016.
Related Publications (1)
Number Date Country
20210045903 A1 Feb 2021 US
Provisional Applications (1)
Number Date Country
62631904 Feb 2018 US
Continuations (1)
Number Date Country
Parent 16183066 Nov 2018 US
Child 17089723 US